Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 15 (RPL7AP15)

Target: RPL7AP15
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L7a pseudogene 15 (RPL7AP15) is a human pseudogene derived from the ribosomal protein L7a gene[1][5][11]. Pseudogenes like RPL7AP15 do not encode functional proteins and are non-coding copies or remnants of protein-coding genes, in this case related to the structural 60S ribosomal subunit protein L7a[1][5][11]. There is no evidence that RPL7AP15 possesses any biological or disease function, and it is not considered a therapeutic target or active molecular entity[1]. The parent gene, ribosomal protein L7a (RPL7A), plays a role in ribosome structure and function, but the pseudogene variant RPL7AP15 is considered functionally inert[4][7].

Other names: RPL7A_1_95RPL7AP15Ribosomal protein L7a pseudogene 15

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 15 (RPL7AP15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 15 (RPL7AP15).

Explore the full profile